Teaching Bangsal Varicella
-
Upload
intan-permata-sari-arifin-dia -
Category
Documents
-
view
26 -
download
1
description
Transcript of Teaching Bangsal Varicella
Coass Coass DermatovenereologyDermatovenereology
Citra RahayuCitra Rahayu
Munirah Binti HamidomMunirah Binti Hamidom
Akmal Hakim Akmal Hakim
Dewi ShintaDewi Shinta
Ahmad NurfakhriAhmad Nurfakhri
Jabar AljufriJabar Aljufri
Nurul Iska UlmarikaNurul Iska Ulmarika
Ruth Fauntin Ruth Fauntin
Trivirasakti JunusTrivirasakti Junus
Daud YusufDaud Yusuf
MukhraeniMukhraeni
Intan Permata Sari A.D.Intan Permata Sari A.D.
Fitri Ani AzisFitri Ani Azis
Sri Suci MardiyantiSri Suci Mardiyanti
Patient’s identityPatient’s identity NameName : Mr. A.S.: Mr. A.S. Sex Sex : Man: Man Age Age : 15 Years Old: 15 Years Old Job Job : Unemployed: Unemployed Address Address : Je’rutallasa St., Jeneponto : Je’rutallasa St., Jeneponto
CountyCounty Status Status : Unmarried: Unmarried Religion Religion : islam: islam
Status presentStatus present
General condition General condition : : SevereSevereConsciousnessConsciousness : Compos mentis : Compos mentis Vital signVital sign ::
BPBP : 100/60 mmHg: 100/60 mmHgPulsePulse : 84x/m: 84x/mRRRR : 24x/m: 24x/mTempTemp : 36ᶿC: 36ᶿC
Cont…….Cont…….
Head Head : Anemic (+/+), Icterus (-), Cyanosis (-): Anemic (+/+), Icterus (-), Cyanosis (-) CorCor : S1/S2 pure reguler : S1/S2 pure reguler Thorax Thorax : vesiculer, Wheezing (-), Ronchi (-): vesiculer, Wheezing (-), Ronchi (-) Abdomen Abdomen : Normal: Normal Extremities Extremities : Normal, no sign of Pretibial : Normal, no sign of Pretibial
Oedema in lower extremities. Oedema in lower extremities. Limphe Limphe : No sign of limphoma, : No sign of limphoma,
palpable pain palpable pain (-) (-)
STATUS STATUS DERMATOLOGISTDERMATOLOGIST
Regio Regio : Regio : Regio GeneralisataGeneralisata
Effloresence : Papul Effloresence : Papul eritematous, eritematous, Vesicle, Vesicle, Pustul, Pustul, Crusta, and Crusta, and Hiperpigmented Hiperpigmented (polimorf lesion)(polimorf lesion)
regioregio : Coli : Coli EffloresensiEffloresensi : (1) vesicel, (2) krusta: (1) vesicel, (2) krusta
Diagnostic Diagnostic ExaminationExamination
Laboratory FindingsLaboratory FindingsWBCWBC : 7,5 x 10: 7,5 x 1033 /mm /mm3 3 RBCRBC : 4,8 x 10: 4,8 x 1066 /mm /mm33
HGBHGB : 13,8 g/dL: 13,8 g/dLHCTHCT : 41,7 %: 41,7 %PLT PLT : 406 x 10: 406 x 1033 / mm / mm33
SGOTSGOT : 24 U/L: 24 U/LSGPTSGPT : 17 U/L: 17 U/L
TherapyTherapyDermatology:Dermatology:
Antiviral : Aciclovyr 5 x 400mg ( 7 days )Antiviral : Aciclovyr 5 x 400mg ( 7 days ) Antihistamin : Interhistin 50 mg 3 x 1Antihistamin : Interhistin 50 mg 3 x 1 Elkana syr 2x 1 cthElkana syr 2x 1 cth Salisil talk Salisil talk Fuson creamFuson cream
Definition Definition Varicella, commonly known Varicella, commonly known
as chickenpox, is the as chickenpox, is the primary infection with the primary infection with the VZV.VZV.
Varicella is characterized by Varicella is characterized by a vesicular eruption a vesicular eruption consisting of delicate consisting of delicate “teardrop” vesicles on an “teardrop” vesicles on an erythematous base.erythematous base.
ETIOLOGI VARICELLA ZOOSTER VIRUS
Lipid envelope surrounding nucleocapsid with icosahedral symmetry
Total diameter of approximately 150–200 nm
Centrally located double-strand DNA with a molecular weight of 80 million
EpidemiologyEpidemiologyVaricella is distrubated Varicella is distrubated
worldwideworldwideSince introduction of Since introduction of
varicella vaccine in 1995, varicella vaccine in 1995, incidence of varicella has incidence of varicella has decreased as vaccination decreased as vaccination coverage has increased. coverage has increased.
Prior to 1995, 3–4 million Prior to 1995, 3–4 million cases in the United States cases in the United States annually. annually.
CLINICAL FINDINGCLINICAL FINDING
Mild febrisMild febris Effloresence : Vesicle Tears drop-like Effloresence : Vesicle Tears drop-like
spreading from body to upper and lower spreading from body to upper and lower extrimities centrifugallyextrimities centrifugally
Itchiness of the whole body.Itchiness of the whole body. May infect upper respiratory tract and May infect upper respiratory tract and
mucosa of the mouthmucosa of the mouth
DIAGNOSEDIAGNOSE
Clinical FeatureClinical FeatureTzanck Test (Datia Tzanck Test (Datia cell with multiple cell with multiple nucleus)nucleus)
TREATMENTTREATMENT
Antiviral : Aciclovyr 5 x 400mg ( 7 days )Antiviral : Aciclovyr 5 x 400mg ( 7 days ) Antihistamin : Interhistin 50mg 3 x 1Antihistamin : Interhistin 50mg 3 x 1 Salisil talk Salisil talk Fuson creamFuson cream
PREVENTIONPREVENTION
Vaccination at the age of 12 months and Vaccination at the age of 12 months and above and revaccination at the age of 4 to 6 above and revaccination at the age of 4 to 6 years old. via subcutaneous injection 0.5ml years old. via subcutaneous injection 0.5ml at the age 12 months till 12 years old.at the age 12 months till 12 years old.
If vaccination is given at the age above 12 If vaccination is given at the age above 12 years old with the same dosage, then years old with the same dosage, then revaccination 4 to 8 weeks. Then antibody revaccination 4 to 8 weeks. Then antibody will appear in 3 to 6 days laterwill appear in 3 to 6 days later
COMPLICATIONCOMPLICATION
EncephalitisEncephalitis PneumoniaPneumonia GlomerulonephritisGlomerulonephritis Keratitis Keratitis Conjunctivitis, etcConjunctivitis, etc
PROGNOSISPROGNOSIS
A better hygiene will result a better A better hygiene will result a better prognosis.prognosis.